Neurol. praxi. 2012;13(2):97-100

Genetic aspects of „idiopathic“ epilepsies

MUDr.Štefania Rusnáková1, RNDr.Lenka Fajkusová, CSc.2, Mgr.Eva Jansová2, Mgr.Pavla Šultesová2, Mgr.Marie Chovančíková, Ph.D.2, doc.MUDr.Robert Kuba, Ph.D.1,3,4, doc.MUDr.Hana Ošlejšková, Ph.D.1
1 Centrum pro epilepsie Brno, Klinika dětské neurologie LF MU a FN Brno
2 Centrum molekulární biologie a genové terapie, LF MU a FN Brno
3 Centrum pro epilepsie Brno, 1. neurologická klinika LF MU a FN u sv. Anny, Brno
4 Výzkumná skupina pro behaviorální a sociální neurovědy CEITEC &ndash,
Středoevropský technologický institut, Masarykova univerzita, Brno

Nowadays we should suppose that epileptology come in the period of DNA and the genetics has become one of main trend of research

in epileptology over the world. Epilepsies in which genetic background is predicted are called “idiopathic”. In recent years genetic

discoveries have shown the central role of ion channels in the pathophysiology of idiopathic epilepsies. Ion channels are divided to

voltage-gated and ligand-gated ion channels. For voltage-gated ion channels, mutation of Na+, K+ and Cl- channels are associated with

forms of generalized epilepsy and infantile seizures syndromes. Mutations in ligand-gated ion channels, such as nicotinic acetylcholine

receptors and GABA receptors, are associated with specific syndromes of frontal and generalized epilepsies, respectively. Mutations in

few genes that do not encode ion channels have been identified in the idiopathic human epilepsies.

In children and young adults are idiopathic epilepsies often, that´ s way identification of the genetic-biological ethiopatogenesy can

perspectively lead to individualization and selection of farmacotherapy in clinical practice. The article suggests the summary of up-todate

discoveries in the field of genetic epilepsy research.

Keywords: epilepsy, epileptic syndrome, genetic, ion channels, channelopathies

Published: April 23, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rusnáková Š, Fajkusová L, Jansová E, Šultesová P, Chovančíková M, Kuba R, Ošlejšková H. Genetic aspects of „idiopathic“ epilepsies. Neurol. praxi. 2012;13(2):97-100.
Download citation

References

  1. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, Boas WE, Engel J, French J, Glauser TA, Mathern W, Moshe SL, Nordli D, Plouin P, Scheffer IE. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia, 2010; 51: 676-685. Go to original source... Go to PubMed...
  2. Charlier C, Singh NA, Ryan SG, Lewis TB, Reus BE, Leach RJ, Leppert M. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nature Genetic 1998; 18: 53-55. Go to original source... Go to PubMed...
  3. Cossette P, Liu L, Brisebois K, Dong H, Lortie A, Vanasse M, Saint-Hilaire JM, Carmant L, Verner A, Lu WY, Wang YT, Rouleau GA. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nature Genetics 2002; 31: 184-189. Go to original source... Go to PubMed...
  4. Kananura C, Haug K, Sander T, Runge U, Gu W, Hallmann K, Rebstock J, Heils A, Steinlein OL. A Splice-Site Mutation in GABRG2 Associated With Childhood Absence Epilepsy and Fibrile Convulsions. Arch Neurol. 2002; 59: 1137-1141. Go to original source... Go to PubMed...
  5. Katzung BG. Základní a klinická farmakologie; H+H 2006, 339-351.
  6. Khosravani H, Bladen C, Parker DB, Snutch TP, McRory JE, Zamponi GW. Effects of Cav3.2 channel mutations linked to idiopathic generalized epilepsy. Annals of Neurology 2005; 57: 745-749. Go to original source... Go to PubMed...
  7. Lagae L. What´s new in: Genetics in childhood epilepsy. Eur J Pediatr, 2008; 167: 715-722. Go to original source... Go to PubMed...
  8. Lee IC, Chen YT. Benign familial neonatal convulsions: novel mutation in a newborn. Paediatr Neurol 2009; 40: 387-391. Go to original source... Go to PubMed...
  9. Lu Y, Wang X. Genes associated with idiopathic epilepsie: a current overview. Neurol Res 2009; 135-43. Go to original source... Go to PubMed...
  10. Maljevic S, Klaus Krampfl MD, Cobilanschi J, Tilgen N, Beyer S, Weber YG, Schlesinger F, Ursu D, Melzer W, Cosette P, Bufler J, Lerche H, Heils A. A mutation in the GABAA receptor ?1-subunit is associated with absence epilepsy. Annals of Neurology 2006; 6: 983-987. Go to original source... Go to PubMed...
  11. Menkes JH, Sarnat BH, Maria BL. Child neurology; Lippincott Williams & Wilkins 2006; 7: 857-860.
  12. Mulley JC, Scheffer IE, Petrou S, Dibbens LM, Berkovic SF, Harkin LA. SCN1A Mutations and epilepsy. Human mutation 2005; 25: 535-542. Go to original source... Go to PubMed...
  13. Mulley JC, Scheffer IE, Petrou S, Berkovi SF. Channelopathies as a genetic cause of epilepsy. Current Opinion in Neurology 2003; 16: 171-176. Go to original source... Go to PubMed...
  14. Ortrud KS. Genetic mechanisms that underlie epilepsy. Nature Reviews Neuroscience 2004; 5: 400-408. Go to original source... Go to PubMed...
  15. Saint-Martin C, Gauvain G, Teodorescu G, Gourfinkel-An I, Fedirko E, Weber YG, Maljevic S, Ernst JP, Garcia-Olivares J, Fahlke C, Nabbout R, LeGuern E, Lerche H, Poncer JC, Depienne C. Two novel CLCN2 mutations accelerationg chloride channel deactivation are associated with idiopathic generalized epilepsy. Hum Mutat. 2009; 30: 397-405. Go to original source... Go to PubMed...
  16. Scheffer IE, Berkovic SF. The genetics of human epilepsy. Neurosciences 2003. Go to original source...
  17. Scheffer IE, Zhang YH. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus? Brain Dev. 2009; 31: 394-400. Go to original source... Go to PubMed...
  18. Strug LJ, Clarke T, Chiang T, Chin M, BAskurt Z, Li W, Dorfman R, Bali B, Wirrell E, Kugler SL, Mandelbaum E, Wolf SM, Mc Goldrick P, Harrison H, Novotny EJ, Ju J. Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4). European Journal of Human Genetics 2009; 17: 1171-1181. Go to original source... Go to PubMed...
  19. Talan J. Genetic Marker Identified for Rolandic Seizures. Neurology Today 2009; 9: 16-17. Go to original source... Go to PubMed...
  20. Wallace R, Scheffer IE, Barnett S, Richards M, Dibbens L, Desai RR, Lerman-Sagie T, Lev D, Mazarib A, Brand N, BenZeev B, Goikhman I, Singh R, Kremmidiotis G, Gardner A, Sutherland GR, George AL, Mulley JC, Berkovic SF. Neuronal Sodium Channel ?1-subunit Mutations in Generalized Epilepsy with Febrile Seizures Plus. The American Journal of Human Genetics 2001; 68: 859-865. Go to original source... Go to PubMed...
  21. Zuberi SM, Brunklaus A, Birch R, Reavey E, Duncan J, Forbes GH. Genotype-phenotype associatons in SCN1A-related epilepsies. Neurology 2011; 76: 5-10. Go to original source... Go to PubMed...
  22. GABA receptor in wikipedia, dostupný na cs.wikipedia.org/wiki/GABA_receptor.
  23. Nicotin acetylcholine recetor in wikipedia, dostupný na en.wikipedia.org/wiki/Nicotinic_acetylcholine_receptor.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.